Test Bank for Abrams’ Clinical Drug Therapy: Rationales for Nursing Practice 13th Edition by Frandsen and Pennington

Understanding why a drug works is just as important as knowing what it does.

That is the philosophy at the heart of Abrams’ Clinical Drug Therapy — and it is the philosophy that separates nurses who administer medications safely from nurses who administer medications with genuine clinical mastery. In nursing practice, knowing a drug’s name and dose is the starting point. Understanding its mechanism of action, anticipating its adverse effects, recognizing its interactions, and applying that knowledge to real patient care decisions — that is the standard that clinical drug therapy demands.

And it is the standard that the NCLEX tests.

This comprehensive test bank is built for the 13th Edition of Abrams’ Clinical Drug Therapy: Rationales for Nursing Practice by Frandsen and Pennington. It is one of the most clinically rigorous and mechanistically thorough pharmacology textbooks in undergraduate and graduate nursing education — and this test bank helps you master every chapter with the focused, rationale-driven, nursing-practice-centered preparation that clinical drug therapy mastery demands.

Whether you are preparing for a pharmacology course exam, an ATI pharmacology assessment, or the NCLEX-RN, this resource delivers the drug knowledge, clinical reasoning depth, and patient safety focus that Abrams’ approach has always demanded — and that nursing practice rewards.

---

What’s Inside?

• Hundreds of practice questions covering every chapter
• Multiple-choice, select-all-that-apply, alternate-format, and Next Generation NCLEX-style clinical scenario questions
• Complete answer keys with thorough, mechanistically grounded pharmacological rationales
• Questions aligned with current NCLEX-RN, NCLEX-PN, and Next Generation NCLEX examination standards
• Coverage of all major drug classifications, clinical rationales, nursing implications, patient education priorities, and pharmacological safety across every body system

---

Who Is This Test Bank For?

This resource is perfect for:

• Undergraduate RN and LPN nursing students in pharmacology and clinical drug therapy courses
• NCLEX-RN and NCLEX-PN candidates seeking comprehensive pharmacology content review
• Nursing students completing ATI pharmacology proctored assessments
• Graduate nursing students reviewing foundational clinical drug therapy principles
• Nursing faculty developing pharmacology and drug therapy course exams and assessments
• LPN-to-RN bridge students updating and expanding clinical pharmacology knowledge
• Nursing students in accelerated BSN or second-degree programs covering pharmacology
• Advanced practice nursing students reviewing undergraduate pharmacological foundations

---

Topics Covered Include:

• Introduction to pharmacology — basic concepts and drug sources
• Pharmacokinetics — absorption, distribution, metabolism, and excretion
• Pharmacodynamics — mechanisms of drug action and drug-receptor theory
• Drug interactions, adverse drug reactions, and medication error prevention
• Nursing process applied to drug therapy — assessment through evaluation
• Drug therapy across the lifespan — pediatric, geriatric, and pregnancy considerations
• Herbal and dietary supplement considerations in clinical practice
• Analgesic drug therapy — opioids, non-opioids, and adjuvant agents
• Anti-inflammatory, antirheumatic, and related drugs
• Drug therapy for hematopoietic disorders
• Immune system drugs — immunosuppressants and immunostimulants
• Anti-infective drug therapy — antibiotics, antivirals, antifungals, and antiparasitics
• Drug therapy for cancer — antineoplastics and targeted therapy
• Central nervous system drug therapy — antidepressants, antipsychotics, and anxiolytics
• Antiepileptic drug therapy and neurological pharmacology
• Drug therapy for Parkinson’s disease and other movement disorders
• Drug therapy for substance abuse disorders
• Drug therapy for hypertension and vascular disorders
• Drug therapy for heart failure and cardiac dysrhythmias
• Anticoagulant, antiplatelet, and thrombolytic drug therapy
• Drug therapy for hyperlipidemia
• Drug therapy for respiratory disorders — bronchodilators and anti-inflammatory agents
• Drug therapy for diabetes mellitus — insulin and oral antidiabetic agents
• Drug therapy for thyroid and other endocrine disorders
• Drug therapy for renal and genitourinary disorders
• Drug therapy for gastrointestinal disorders
• Drug therapy for reproductive disorders and women’s health
• Drug therapy for ophthalmic and dermatological conditions
• Drug therapy for weight management and nutritional supplementation

---

Why This Test Bank Delivers Results

Abrams’ Clinical Drug Therapy has earned its reputation as one of nursing education’s most demanding and most rewarding pharmacology resources because of one word — rationales.

Every drug discussion in Frandsen and Pennington’s 13th Edition is built around clinical rationale. Not just what the drug does — but why it works that way, why it causes the adverse effects it does, why certain patients need dose adjustments, why specific drug combinations are dangerous, and why the nursing implications for each drug class are what they are. That mechanistic, rationale-driven approach is what produces nurses who do not just administer drugs — they understand them.

This test bank is built to the same standard.

Every question in this test bank is grounded in clinical rationale — the same framework that Frandsen and Pennington embed throughout the 13th Edition. You will not simply identify a drug’s classification. You will explain why an ACE inhibitor causes the dry cough it does — and what physiological mechanism that represents. You will not just list vancomycin’s adverse effects. You will recognize the specific assessment finding that signals nephrotoxicity is developing and determine the priority nursing response. You will not merely recall that warfarin interacts with many drugs — you will understand which specific enzyme pathway each interaction involves and how that changes your patient monitoring plan.

The 13th Edition reflects the most current FDA drug approvals, updated black box warnings, revised clinical guidelines, and the Next Generation NCLEX clinical judgment integration. This test bank is fully aligned with every update — including NGN-style clinical scenario questions that challenge you to recognize cues, analyze information, prioritize hypotheses, generate solutions, take actions, and evaluate outcomes in complex drug therapy patient care contexts.

Detailed rationales explain the pharmacological mechanisms, nursing process applications, patient safety principles, and clinical reasoning behind every correct answer. Questions are organized chapter by chapter for structured, systematic study. Target drug classes where your clinical rationale understanding is weakest. Return to high-yield pharmacological categories as your NCLEX or course exam approaches. Build the drug therapy mastery that Abrams’ approach has always demanded — and that every patient deserves from their nurse.

---

Sample Questions

Question 1
A nurse is administering IV amphotericin B to a patient with systemic fungal infection. The patient develops fever, chills, rigors, and hypotension 30 minutes into the infusion. Which nursing action is the priority and which clinical understanding best explains this reaction?

• A) Stop the infusion permanently — this is anaphylaxis requiring immediate epinephrine administration
• B) Slow the infusion rate, administer prescribed premedications including antipyretics and antihistamines, and notify the provider — this is an infusion-related reaction common with amphotericin B
• C) Increase the infusion rate to deliver the full dose before symptoms worsen — tolerance will develop
• D) Discontinue the amphotericin B permanently and switch to an oral antifungal agent immediately

Correct Answer: B
Rationale: Amphotericin B is notorious for infusion-related reactions — a predictable, non-immune-mediated response that occurs in the majority of patients receiving conventional amphotericin B deoxycholate. The mechanism involves amphotericin B binding to cholesterol in immune cell membranes, triggering direct release of inflammatory mediators including interleukins and tumor necrosis factor — producing fever, chills, rigors, hypotension, and nausea during infusion. This is not anaphylaxis — it does not involve IgE-mediated mast cell degranulation and does not require epinephrine. Standard management involves slowing the infusion rate, administering prescribed premedications — acetaminophen, diphenhydramine, and sometimes meperidine for rigors — and notifying the provider. Premedication before subsequent infusions significantly reduces reaction severity. Increasing the infusion rate worsens the reaction by delivering a higher drug load more rapidly. Permanent discontinuation is premature for a predictable infusion reaction — particularly when amphotericin B may be the only effective agent for the patient’s specific fungal infection. Lipid-based amphotericin B formulations produce fewer infusion reactions if conventional formulation is not tolerated.

---

Question 2
A nurse is caring for a patient who has been taking prednisone 40 mg daily for six weeks for severe rheumatoid arthritis. The provider has decided to discontinue the medication. Which nursing action and patient education is most critical regarding the discontinuation of long-term corticosteroid therapy?

• A) Instruct the patient to stop the prednisone immediately since the treatment course is complete
• B) Explain that prednisone must be tapered gradually under provider guidance to allow the hypothalamic-pituitary-adrenal axis to recover and prevent adrenal crisis
• C) Advise the patient to switch to an over-the-counter hydrocortisone cream as a safe alternative during discontinuation
• D) Inform the patient that abrupt discontinuation is safe as long as they are not experiencing active rheumatoid arthritis symptoms

Correct Answer: B
Rationale: Long-term systemic corticosteroid therapy — particularly at doses above physiological replacement levels and for durations exceeding two to three weeks — suppresses the hypothalamic-pituitary-adrenal axis through negative feedback inhibition. Exogenous corticosteroids signal the hypothalamus and pituitary to reduce CRH and ACTH secretion, which in turn causes the adrenal cortex to decrease endogenous cortisol production. With prolonged suppression, the adrenal cortex atrophies and loses its capacity to produce adequate cortisol. If systemic corticosteroids are abruptly discontinued, the suppressed HPA axis cannot mount a sufficient cortisol response — resulting in adrenal insufficiency or adrenal crisis — a potentially life-threatening emergency presenting with severe hypotension, weakness, nausea, vomiting, and circulatory collapse. A gradual tapering schedule — reducing the dose incrementally over weeks — allows the HPA axis to recover and resume normal cortisol production. This is one of the most critical corticosteroid drug therapy safety principles in nursing practice. Topical hydrocortisone does not provide systemic HPA axis recovery. Abrupt discontinuation is never safe after six weeks of therapeutic-dose corticosteroid use.

---

Question 3
A nurse is reviewing the medication list of a patient admitted for a COPD exacerbation who takes theophylline 300 mg orally twice daily at home. The patient also smokes one pack of cigarettes per day and was recently started on ciprofloxacin for a respiratory infection. Which clinical concern requires the most immediate nursing follow-up?

• A) The combination of theophylline and ciprofloxacin increases theophylline metabolism, reducing drug efficacy and requiring a dose increase
• B) Ciprofloxacin inhibits CYP1A2 — the primary enzyme metabolizing theophylline — significantly elevating theophylline plasma levels and increasing toxicity risk
• C) Cigarette smoking enhances ciprofloxacin absorption, increasing antibiotic effectiveness in respiratory infections
• D) The combination of theophylline and ciprofloxacin causes additive bronchodilation, which may overcorrect the COPD exacerbation

Correct Answer: B
Rationale: This combination represents one of the most clinically significant drug interactions in pulmonary pharmacology. Theophylline has a narrow therapeutic index — therapeutic range 5–15 mcg/mL — making it highly susceptible to drug interactions that alter its metabolism. Ciprofloxacin is a potent inhibitor of CYP1A2 — the primary cytochrome P450 enzyme responsible for theophylline metabolism. When ciprofloxacin is added to a stable theophylline regimen, theophylline clearance is dramatically reduced, causing drug accumulation and elevated plasma levels. Theophylline toxicity presents with nausea, vomiting, tachycardia, tremors, and at severe levels — seizures and cardiac dysrhythmias. The nurse must notify the provider immediately, anticipate a theophylline dose reduction or serum level monitoring, and assess the patient for early toxicity signs. Smoking actually induces CYP1A2 — increasing theophylline metabolism and lowering levels — which means this hospitalized patient who is likely not smoking will experience further elevation of theophylline levels beyond the ciprofloxacin effect alone. This creates a compounded toxicity risk requiring urgent clinical attention.

---

Question 4
A nurse is caring for a patient with chronic kidney disease stage 4 who is being treated for a urinary tract infection. The provider has prescribed nitrofurantoin. Which nursing action reflects the most appropriate application of clinical drug therapy rationale?

• A) Administer the nitrofurantoin as prescribed — it is the first-line treatment for all urinary tract infections
• B) Contact the provider to question the order — nitrofurantoin requires adequate renal function for urinary concentration and is contraindicated in significant renal impairment
• C) Administer the nitrofurantoin and monitor creatinine levels daily for signs of nephrotoxicity
• D) Crush the nitrofurantoin tablet and mix with juice to improve absorption in a patient with renal impairment

Correct Answer: B
Rationale: Nitrofurantoin is a urinary tract-specific antibiotic that works by being concentrated in the urine through renal excretion — its antimicrobial activity depends entirely on achieving adequate urinary drug concentrations. In patients with significant renal impairment — defined as eGFR below 30–45 mL/min/1.73m², corresponding to CKD stage 3b-4 — the kidneys cannot adequately concentrate nitrofurantoin in the urine, rendering the drug therapeutically ineffective for treating the infection. Additionally, impaired renal excretion causes systemic drug accumulation, increasing the risk of serious toxicity — including peripheral neuropathy and pulmonary toxicity. Current prescribing guidelines and FDA labeling contraindicate nitrofurantoin when eGFR falls below 30 mL/min. The nurse must apply the clinical rationale of understanding why this drug cannot work in this patient — not simply administer it because it is ordered. This question exemplifies the Abrams’ philosophy — understanding rationale, not just compliance. The provider must be notified and an alternative antibiotic appropriate for the patient’s renal function level selected.

---

Question 5
A nurse is providing medication teaching to a patient newly prescribed lithium carbonate for bipolar I disorder. The patient lives alone and is very physically active. Which patient statement indicates the most critical need for additional teaching?

• A) “I will keep all of my scheduled blood level monitoring appointments.”
• B) “I should drink plenty of fluids — at least eight to ten glasses of water daily.”
• C) “When I exercise heavily and sweat a lot I can skip my sodium intake since salt is bad for me.”
• D) “I will contact my provider before starting any new medications including over-the-counter drugs.”

Correct Answer: C
Rationale: This statement reflects a dangerous misunderstanding that requires immediate and emphatic correction. Sodium balance is a critical pharmacokinetic determinant of lithium levels — lithium and sodium are both monovalent cations that compete for reabsorption in the renal proximal tubule. When sodium intake decreases or sodium loss increases — through sweating, diarrhea, vomiting, or low-sodium diets — the kidney compensates by reabsorbing more sodium in the proximal tubule. Because lithium competes with sodium for this reabsorption mechanism, increased proximal tubule sodium reabsorption causes increased lithium reabsorption as well — elevating serum lithium levels toward toxic range. A physically active patient who sweats heavily and simultaneously restricts sodium intake creates a perfect pharmacokinetic storm for lithium toxicity — presenting with nausea, tremors, ataxia, confusion, and at severe levels — seizures and cardiac dysrhythmias. The patient must maintain consistent sodium intake and increase fluid and electrolyte replacement during heavy exercise. All other statements reflect correct understanding — therapeutic drug monitoring, adequate hydration, and drug interaction awareness are all essential components of safe lithium therapy.

---

Frequently Asked Questions (FAQs)

What edition does this test bank cover?
This test bank is written specifically for the 13th Edition of Abrams’ Clinical Drug Therapy: Rationales for Nursing Practice by Frandsen and Pennington. All questions are fully aligned with the current edition’s chapter organization, updated drug content, current FDA safety communications, Next Generation NCLEX clinical judgment integration, and current evidence-based nursing pharmacology practice standards.

How are the questions organized?
Questions are arranged chapter by chapter, allowing you to study systematically through all clinical drug therapy content or focus on specific drug classes — such as anti-infectives, cardiovascular agents, or CNS medications — based on your course exam schedule or NCLEX preparation priorities. The clinical rationale framework is integrated throughout every chapter’s question set.

Is this test bank aligned with the NCLEX and Next Generation NCLEX?
Yes. Questions are written to reflect current NCLEX-RN and NCLEX-PN examination standards and incorporate the clinical judgment emphasis of the Next Generation NCLEX framework. The pharmacological and parenteral therapy client needs category is one of the most heavily weighted on the NCLEX — this test bank directly targets that content with the clinical rationale depth and NGN-aligned scenario construction the examination demands.

How does this test bank differ from other nursing pharmacology test banks?
This test bank is built specifically around the clinical rationale framework that makes Abrams’ textbook unique in nursing pharmacology education. While other pharmacology test banks focus on drug facts and nursing implications, this test bank emphasizes the mechanistic understanding — the why behind every drug therapy decision — that Frandsen and Pennington embed throughout the 13th Edition. That depth of clinical rationale is what distinguishes this resource.

Is this test bank useful for both undergraduate and graduate nursing students?
Yes. While the 13th Edition is primarily used in undergraduate nursing pharmacology courses, its clinical rationale depth and mechanistic approach make this test bank equally valuable for graduate nursing students reviewing foundational drug therapy principles for advanced practice coursework or APRN certification preparation.

How quickly can I access the test bank after purchase?
Immediately. As soon as your purchase is complete, you receive instant digital access with no waiting period. Study on your own schedule, at your own pace, from any device.

Are the rationales mechanistically detailed enough to reflect the Abrams’ clinical rationale approach?
Yes. Every rationale is written to explain the pharmacological mechanism, clinical rationale, nursing process application, and patient safety principle behind the correct answer — not just identify it. This approach directly mirrors the rationale-driven philosophy of Frandsen and Pennington’s textbook and builds the drug therapy mastery that clinical nursing practice demands.

Can nursing faculty use this test bank for course assessments?
Absolutely. The chapter-by-chapter organization, clinical rationale emphasis, NGN-aligned question formats, and mechanistic rationale construction make this an outstanding resource for faculty building unit exams, ATI-style assessments, and comprehensive pharmacology course finals for undergraduate and graduate nursing programs.